Delivery Order SPE2DB22D1202-SPE2DB25FVLK2
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Isotretinoin 30 mg capsules (30-count) with a contract ceiling value of $1,645.60. This firm fixed-price delivery order, with an ultimate completion date of September 15, 2025, was competitively awarded with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Isotretinoin 30 mg capsules in quantities of ten. This competitively awarded, non-set-aside contract carries a ceiling value of $1,873.80 and features firm fixed-price pricing, with an ultimate completion date of September 9, 2025. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,584.30 to AmerisourceBergen Drug Corp for Isotretinoin 20 mg capsules (30-count packaging) on September 8, 2025, with an ultimate completion date of September 9, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is performed at the contractor's Conshohocken, Pennsylvania location. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Department of Defense's Medical Supply Chain awarded a delivery order contract to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Isotretinoin 30 mg capsules in quantities of 30 units, with a contract ceiling value of $17,955.69. This is a firm fixed-price delivery order with an ultimate completion date of August 6, 2025, and was awarded without a set-aside designation, indicating it was awarded through open competition. The contract is executed from AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $4,958.75 to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (30-count packaging) on September 9, 2025, with an ultimate completion date of September 10, 2025. This firm fixed-price, non-set-aside contract was awarded competitively and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 vehicle running...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,107.60 for Isotretinoin 30 mg capsules (30-count units) on September 12, 2025, with a completion date of September 15, 2025. This is a firm fixed price, non-set-aside contract to be performed at the contractor's Conshohocken, Pennsylvania facility. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency (DLA) awarded a $1,567.08 delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Isotretinoin 40 mg capsules (30-count). This is a firm fixed price, competitively awarded contract with no set-aside designation, scheduled for completion by June 2, 2025. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its corporate headquarters and primary distribution operations. This...
- The Defense Logistics Agency awarded a $3,976.16 firm fixed-price delivery order to AmerisourceBergen Drug Corp on June 9, 2025, for the supply of Isotretinoin 30 mg capsules (30-count units). This is a non-set-aside contract with a performance location in Conshohocken, Pennsylvania, and an ultimate completion date of June 10, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,085.34 by the Defense Logistics Agency (DLA) on August 26, 2025, for the supply of Isotretinoin 30 mg capsules (30-count packaging). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 27, 2025. The contract will be performed at the awardee's Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $2,868.79 to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (30-count units) on September 15, 2025, with completion scheduled for September 16, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with DLA. The work will be performed at the contractor's corporate...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB25FVLK2Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Isotretinoin 30 mg capsules (30-count units) on September 15, 2025, with a ceiling value of $6,658.02 and a firm fixed price structure. This non-set-aside, competitively awarded contract is scheduled for completion by September 16, 2025, with performance occurring at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's ongoing pharmaceutical supply support to the federal government. This award is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion global pharmaceutical support vehicle extending through December 2026. As a major pharmaceutical distributor, AmerisourceBergen supplies critical medications and medical products to support military healthcare programs and other federal medical procurement needs. The company's portfolio demonstrates extensive experience fulfilling federal requirements across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and medical supplies for Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.7k | 9/15/25 |